As its director, Manusis outlines the facility’s role in delivering advanced, personalized solutions to improve vision and ...

Eyestem has announced the completion of its phase 1 study for its investigational retinal pigment epithelium (RPE) cell ...

A look at current therapies, clinical trial results, patient education, and emerging options for managing this progressive ...

Assistive devices empower patients with central vision loss to regain independence, enhancing daily activities and reducing ...

From laser vision correction to adjustable lens implants, the Center for Refractive Solutions at New York Eye and Ear ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Aldeyra had received 2 complete response letters (CRL) from the FDA in April 2025 and November 2023 for past submissions.

Ocugen has announced the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to ...

The center aims to optimize patients' vision with a range of cataract and corneal refractive procedures and minimize reliance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Funding will support continued product development, while the board is composed of “global leaders in posterior and anterior ...

Patients in Ontario expose illegal user fees for cataract surgeries in private clinics, urging government action to uphold ...